TickerFactsScreenerDevelopers

MYRIAD GENETICS INC (MYGN) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $425.65M2009: $434.22M2010: $557.58M2011: $566.79M2012: $635.80M2013: $728.60M2014: $719.00M2015: $661.70M2016: $739.60M2017: $768.40M2018: $966.10M2019: $1.09B2020: $881.00M2021: $967.80M2022: $885.80M2023: $783.20M2024: $701.10M2025: $368.00M$368.00M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$368.00M-47.5%
2024$701.10M-10.5%
2023$783.20M-11.6%
2022$885.80M-8.5%
2021$967.80M+9.9%
2020$881.00M-19.1%
2019$1.09B+12.7%
2018$966.10M+25.7%
2017$768.40M+3.9%
2016$739.60M+11.8%
2015$661.70M-8.0%
2014$719.00M-1.3%
2013$728.60M+14.6%
2012$635.80M+12.2%
2011$566.79M+1.7%
2010$557.58M+28.4%
2009$434.22M+2.0%
2008$425.65M—